Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer.
Saved in:
| Title: | Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer. |
|---|---|
| Authors: | Lot Aronson S; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Amsterdam, The Netherlands., van Stein RM; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands., Algera MD; Scientific Bureau, Dutch Institute for Clinical Auditing (DICA), Leiden, The Netherlands; Maastricht University Medical Center, Department of Obstetrics and Gynecology, Maastricht, The Netherlands; GROW- School for Oncology and Reproduction, Maastricht, The Netherlands., Lopez-Yurda M; The Netherlands Cancer Institute, Department of Biometrics, Amsterdam, The Netherlands., van der Aa MA; Netherlands Comprehensive Cancer Organization (IKNL), Department of Research & Development, Utrecht, The Netherlands., Lok CAR; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Sonke GS; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Amsterdam, The Netherlands., van Driel WJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands. Electronic address: w.v.driel@nki.nl. |
| Corporate Authors: | Dutch OVHIPEC study group |
| Source: | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2026 Jul; Vol. 36 (7), pp. 104500. Date of Electronic Publication: 2026 Jan 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
